Antibody cocktail against SARS-CoV-2 spike protein Grant US-11834493-B2 United States of America 05 Dec 2023
ANTIBODIES FOR PROPHYLAXIS OR TREATMENT OF SARS- COV-2 INFECTIONS Application WO-2023213787-A1 World Intellectual Property Organisation (WIPO) 09 Nov 2023
ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CORONAVIRUS SARS-COV-2 Application WO-2023156636-A1 World Intellectual Property Organisation (WIPO) 24 Aug 2023
ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CORONAVIRUS SARS-COV-2 Application EP-4230650-A1 European Patent Office 23 Aug 2023
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-11732030-B2 United States of America 22 Aug 2023
NOVEL SARS-COV-2 NEUTRALIZING ANTIBODIES Application WO-2023089107-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
NOVEL SARS-COV-2 NEUTRALIZING ANTIBODIES Application EP-4183800-A1 European Patent Office 24 May 2023
COMPOSITIONS Application WO-2023084055-A1 World Intellectual Property Organisation (WIPO) 19 May 2023
NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARBECOVIRUSES Application WO-2023073441-A1 World Intellectual Property Organisation (WIPO) 04 May 2023
POTENTLY NEUTRALIZING NOVEL HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 (COVID-19) Application WO-2023026207-A1 World Intellectual Property Organisation (WIPO) 02 Mar 2023
A SURROGATE CELL-BASED CORONA VIRUS SPIKE PROTEIN BLOCKING ASSAY Application WO-2023006267-A1 World Intellectual Property Organisation (WIPO) 02 Feb 2023
A SURROGATE CELL-BASED CORONA VIRUS SPIKE PROTEIN BLOCKING ASSAY Application EP-4124865-A1 European Patent Office 01 Feb 2023
SHARK VNARS FOR TREATING COVID-19 Application WO-2022260877-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2022
IMMUNE CELL COUNTING OF SARS-COV-2 PATIENTS BASED ON IMMUNE REPERTOIRE SEQUENCING Application WO-2022207682-A1 World Intellectual Property Organisation (WIPO) 06 Oct 2022
ANTIBODIES TARGETING THE SPIKE PROTEIN OF CORONAVIRUSES Application WO-2022173670-A1 World Intellectual Property Organisation (WIPO) 18 Aug 2022
ANTIBODIES NEUTRALIZING SARS-COV-2 Application WO-2022153212-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
Anti-SARS-COV-2 antibodies and uses thereof Grant US-11365239-B2 United States of America 21 Jun 2022
SARS-COV-2 ANTIGEN-BINDING PROTEINS AND USES THEREOF Application WO-2022099187-A3 World Intellectual Property Organisation (WIPO) 16 Jun 2022
ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES Application WO-2022115538-A1 World Intellectual Property Organisation (WIPO) 02 Jun 2022
NEUTRALIZING ANTIBODY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME TYPE II CORONAVIRUS (SARS-C… Application WO-2022110962-A1 World Intellectual Property Organisation (WIPO) 02 Jun 2022
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2… Grant US-11345741-B2 United States of America 31 May 2022
SARS COV-2 NEUTRALIZING ANTIBODIES Application WO-2022079606-A1 World Intellectual Property Organisation (WIPO) 21 Apr 2022
Recombinant mumps virus particle, composition and application thereof Application CN-114316071-A China 12 Apr 2022
ANTIBODY MOLECULES TO CORONAVIRUS AND USES THEREOF Application WO-2022026592-A3 World Intellectual Property Organisation (WIPO) 24 Mar 2022
NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 Application WO-2022053056-A1 World Intellectual Property Organisation (WIPO) 17 Mar 2022
NOVEL DNA SEQUENCES ENCODING HUMAN SCFVs ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST… Application WO-2022053188-A1 World Intellectual Property Organisation (WIPO) 17 Mar 2022
CORONA VIRUS SPIKE PROTEIN-TARGETING ANTIBODIES AND USE THEREOF Application WO-2022023292-A3 World Intellectual Property Organisation (WIPO) 10 Mar 2022
MODIFIED POLYPEPTIDES WITH IMPROVED PROPERTIES Application WO-2022043908-A1 World Intellectual Property Organisation (WIPO) 03 Mar 2022
ANTI-SARS CORONA VIRUS-2 SPIKE PROTEIN ANTIBODIES Application WO-2022027037-A1 World Intellectual Property Organisation (WIPO) 03 Feb 2022
NEUTRALIZING ANTIBODIES TO SARS CORONAVIRUS-2 Application WO-2022003530-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022
MULTISPECIFIC CORONAVIRUS ANTIBODIES Application WO-2022006562-A1 World Intellectual Property Organisation (WIPO) 06 Jan 2022
STEREOTYPIC NEUTRALIZING VH CLONOTYPES AGAINST SARS-COV-2 RBD IN COVID-19 PATIENTS AND… Application WO-2021260532-A1 World Intellectual Property Organisation (WIPO) 30 Dec 2021
HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) Application WO-2021245184-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
HUMAN RECOMBINANT MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE GLYCOPROTEIN Application WO-2021239949-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Application WO-2021242815-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
NEUTRALIZING ANTIBODIES AGAINST SARS-RELATED CORONAVIRUS Application WO-2021239935-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
NOVEL COV-2 ANTIBODIES Application WO-2021233913-A1 World Intellectual Property Organisation (WIPO) 25 Nov 2021
METHOD FOR PREPARING ANTIGEN-BINDING UNIT Application WO-2021228135-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021
ANTI-NOVEL CORONAVIRUS MONOCLONAL ANTIBODY AND APPLICATION THEREOF Application WO-2021218947-A1 World Intellectual Property Organisation (WIPO) 04 Nov 2021
ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME Application WO-2021211775-A1 World Intellectual Property Organisation (WIPO) 21 Oct 2021
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2… Application WO-2021195418-A1 World Intellectual Property Organisation (WIPO) 30 Sep 2021
Targeted delivery of molecules using impedance-based monitoring at elevated temperatures Grant US-11123554-B2 United States of America 21 Sep 2021
CORONAVIRUS VACCINES Application WO-2021170869-A1 World Intellectual Property Organisation (WIPO) 02 Sep 2021
ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME Application WO-2021158521-A1 World Intellectual Property Organisation (WIPO) 12 Aug 2021
Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments Grant US-10975139-B1 United States of America 13 Apr 2021
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-10954289-B1 United States of America 23 Mar 2021
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-10787501-B1 United States of America 29 Sep 2020